// App-Quantinova.ai

1100 : Cerebrospinal α-synuclein RT-QuIC in pathologically-confirmed Multiple System Atrophy

Researchers

Presenter

  • A. Symonds

Principal Investigators

  • G. Fairfoul

  • A. Green

  • D. Breen

Medical Centers

  • N/A

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Multiple system atrophy

  • Parkinson's disease

Biomarkers

  • Alpha-synuclein

  • Cerebrospinal fluid

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Double Blind/Blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A